GE HealthCare Leverages AI Cardiac Imaging in $20B Market and Gains Momentum Rating
GE HealthCare is among leading firms converting AI cardiac imaging validation into hospital deployments with the AI medical imaging market projected at nearly $20 billion by 2033, a 34.7% CAGR and $2.64 billion echocardiography segment by 2030. Zacks Style Scores identify GE HealthCare as a top momentum stock.
1. AI Cardiac Imaging Deployments
GE HealthCare is converting clinically validated AI-enhanced cardiac imaging platforms into contracted hospital deployments, tapping into a global AI medical imaging market projected to reach nearly $20 billion by 2033, with echocardiography alone forecast to hit $2.64 billion by 2030.
2. Momentum Stock Recognition
Zacks Style Scores rate GE HealthCare as a top momentum stock based on its recent performance and growth metrics, highlighting investor interest in companies demonstrating strong upward price trends and financial momentum.